Global Gestational Diabetes Treatment Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Gestational diabetes can be defined as a type of diabetes that affects pregnant women. It is usually a temporary condition which develops during pregnancy and subsides after the birth of the baby. However, there are possibilities that diabetes may return in the later stages of life as type II diabetes mellitus. It is the inability of insulin to absorb the sugars consumed as part of the meal. It may be caused due to insulin resistance in a woman s body because of increasing levels of placental hormones being produced to sustain the development of the fetus. This condition starts when the female body is not able to make and use required amounts of insulin needed in pregnancy, resulting in a build-up of sugar in the bloodstream causing hyperglycemia.
LPI (LP Information)' newest research report, the “Gestational Diabetes Treatment Industry Forecast” looks at past sales and reviews total world Gestational Diabetes Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Gestational Diabetes Treatment sales for 2023 through 2029. With Gestational Diabetes Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gestational Diabetes Treatment industry.
This Insight Report provides a comprehensive analysis of the global Gestational Diabetes Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gestational Diabetes Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gestational Diabetes Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gestational Diabetes Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gestational Diabetes Treatment.
The global Gestational Diabetes Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gestational Diabetes Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gestational Diabetes Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gestational Diabetes Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gestational Diabetes Treatment players cover Biocon Limited, Eli Lilly, Novo Nordisk, Boehringer Ingelheim GmbH, Sanofi S.A., Sun Pharmaceutical Industries Limited, Merck, Novartis and Adocia, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gestational Diabetes Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Gestational diabetes can be defined as a type of diabetes that affects pregnant women. It is usually a temporary condition which develops during pregnancy and subsides after the birth of the baby. However, there are possibilities that diabetes may return in the later stages of life as type II diabetes mellitus. It is the inability of insulin to absorb the sugars consumed as part of the meal. It may be caused due to insulin resistance in a woman s body because of increasing levels of placental hormones being produced to sustain the development of the fetus. This condition starts when the female body is not able to make and use required amounts of insulin needed in pregnancy, resulting in a build-up of sugar in the bloodstream causing hyperglycemia.
LPI (LP Information)' newest research report, the “Gestational Diabetes Treatment Industry Forecast” looks at past sales and reviews total world Gestational Diabetes Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Gestational Diabetes Treatment sales for 2023 through 2029. With Gestational Diabetes Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gestational Diabetes Treatment industry.
This Insight Report provides a comprehensive analysis of the global Gestational Diabetes Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gestational Diabetes Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gestational Diabetes Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gestational Diabetes Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gestational Diabetes Treatment.
The global Gestational Diabetes Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gestational Diabetes Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gestational Diabetes Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gestational Diabetes Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gestational Diabetes Treatment players cover Biocon Limited, Eli Lilly, Novo Nordisk, Boehringer Ingelheim GmbH, Sanofi S.A., Sun Pharmaceutical Industries Limited, Merck, Novartis and Adocia, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gestational Diabetes Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Insulin
- SGLT-2 Inhibitors
- Alpha-glucosidase Inhibitors
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biocon Limited
- Eli Lilly
- Novo Nordisk
- Boehringer Ingelheim GmbH
- Sanofi S.A.
- Sun Pharmaceutical Industries Limited
- Merck
- Novartis
- Adocia
- Peptron
- AstraZeneca plc
- Pfizer, Inc
- Takeda Pharmaceutical Company Ltd
- Abbott
- Antares Pharma
- INJEX Pharma AG
- Daiichi Sankyo
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gestational Diabetes Treatment Market Size 2018-2029
2.1.2 Gestational Diabetes Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gestational Diabetes Treatment Segment by Type
2.2.1 Insulin
2.2.2 SGLT-2 Inhibitors
2.2.3 Alpha-glucosidase Inhibitors
2.2.4 Others
2.3 Gestational Diabetes Treatment Market Size by Type
2.3.1 Gestational Diabetes Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gestational Diabetes Treatment Market Size Market Share by Type (2018-2023)
2.4 Gestational Diabetes Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Gestational Diabetes Treatment Market Size by Application
2.5.1 Gestational Diabetes Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gestational Diabetes Treatment Market Size Market Share by Application (2018-2023)
3 GESTATIONAL DIABETES TREATMENT MARKET SIZE BY PLAYER
3.1 Gestational Diabetes Treatment Market Size Market Share by Players
3.1.1 Global Gestational Diabetes Treatment Revenue by Players (2018-2023)
3.1.2 Global Gestational Diabetes Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Gestational Diabetes Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GESTATIONAL DIABETES TREATMENT BY REGIONS
4.1 Gestational Diabetes Treatment Market Size by Regions (2018-2023)
4.2 Americas Gestational Diabetes Treatment Market Size Growth (2018-2023)
4.3 APAC Gestational Diabetes Treatment Market Size Growth (2018-2023)
4.4 Europe Gestational Diabetes Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Gestational Diabetes Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gestational Diabetes Treatment Market Size by Country (2018-2023)
5.2 Americas Gestational Diabetes Treatment Market Size by Type (2018-2023)
5.3 Americas Gestational Diabetes Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gestational Diabetes Treatment Market Size by Region (2018-2023)
6.2 APAC Gestational Diabetes Treatment Market Size by Type (2018-2023)
6.3 APAC Gestational Diabetes Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gestational Diabetes Treatment by Country (2018-2023)
7.2 Europe Gestational Diabetes Treatment Market Size by Type (2018-2023)
7.3 Europe Gestational Diabetes Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gestational Diabetes Treatment by Region (2018-2023)
8.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GESTATIONAL DIABETES TREATMENT MARKET FORECAST
10.1 Global Gestational Diabetes Treatment Forecast by Regions (2024-2029)
10.1.1 Global Gestational Diabetes Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Gestational Diabetes Treatment Forecast
10.1.3 APAC Gestational Diabetes Treatment Forecast
10.1.4 Europe Gestational Diabetes Treatment Forecast
10.1.5 Middle East & Africa Gestational Diabetes Treatment Forecast
10.2 Americas Gestational Diabetes Treatment Forecast by Country (2024-2029)
10.2.1 United States Gestational Diabetes Treatment Market Forecast
10.2.2 Canada Gestational Diabetes Treatment Market Forecast
10.2.3 Mexico Gestational Diabetes Treatment Market Forecast
10.2.4 Brazil Gestational Diabetes Treatment Market Forecast
10.3 APAC Gestational Diabetes Treatment Forecast by Region (2024-2029)
10.3.1 China Gestational Diabetes Treatment Market Forecast
10.3.2 Japan Gestational Diabetes Treatment Market Forecast
10.3.3 Korea Gestational Diabetes Treatment Market Forecast
10.3.4 Southeast Asia Gestational Diabetes Treatment Market Forecast
10.3.5 India Gestational Diabetes Treatment Market Forecast
10.3.6 Australia Gestational Diabetes Treatment Market Forecast
10.4 Europe Gestational Diabetes Treatment Forecast by Country (2024-2029)
10.4.1 Germany Gestational Diabetes Treatment Market Forecast
10.4.2 France Gestational Diabetes Treatment Market Forecast
10.4.3 UK Gestational Diabetes Treatment Market Forecast
10.4.4 Italy Gestational Diabetes Treatment Market Forecast
10.4.5 Russia Gestational Diabetes Treatment Market Forecast
10.5 Middle East & Africa Gestational Diabetes Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Gestational Diabetes Treatment Market Forecast
10.5.2 South Africa Gestational Diabetes Treatment Market Forecast
10.5.3 Israel Gestational Diabetes Treatment Market Forecast
10.5.4 Turkey Gestational Diabetes Treatment Market Forecast
10.5.5 GCC Countries Gestational Diabetes Treatment Market Forecast
10.6 Global Gestational Diabetes Treatment Forecast by Type (2024-2029)
10.7 Global Gestational Diabetes Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biocon Limited
11.1.1 Biocon Limited Company Information
11.1.2 Biocon Limited Gestational Diabetes Treatment Product Offered
11.1.3 Biocon Limited Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biocon Limited Main Business Overview
11.1.5 Biocon Limited Latest Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Information
11.2.2 Eli Lilly Gestational Diabetes Treatment Product Offered
11.2.3 Eli Lilly Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Eli Lilly Main Business Overview
11.2.5 Eli Lilly Latest Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Information
11.3.2 Novo Nordisk Gestational Diabetes Treatment Product Offered
11.3.3 Novo Nordisk Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Novo Nordisk Main Business Overview
11.3.5 Novo Nordisk Latest Developments
11.4 Boehringer Ingelheim GmbH
11.4.1 Boehringer Ingelheim GmbH Company Information
11.4.2 Boehringer Ingelheim GmbH Gestational Diabetes Treatment Product Offered
11.4.3 Boehringer Ingelheim GmbH Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Boehringer Ingelheim GmbH Main Business Overview
11.4.5 Boehringer Ingelheim GmbH Latest Developments
11.5 Sanofi S.A.
11.5.1 Sanofi S.A. Company Information
11.5.2 Sanofi S.A. Gestational Diabetes Treatment Product Offered
11.5.3 Sanofi S.A. Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Sanofi S.A. Main Business Overview
11.5.5 Sanofi S.A. Latest Developments
11.6 Sun Pharmaceutical Industries Limited
11.6.1 Sun Pharmaceutical Industries Limited Company Information
11.6.2 Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Product Offered
11.6.3 Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Sun Pharmaceutical Industries Limited Main Business Overview
11.6.5 Sun Pharmaceutical Industries Limited Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Gestational Diabetes Treatment Product Offered
11.7.3 Merck Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Gestational Diabetes Treatment Product Offered
11.8.3 Novartis Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Novartis Main Business Overview
11.8.5 Novartis Latest Developments
11.9 Adocia
11.9.1 Adocia Company Information
11.9.2 Adocia Gestational Diabetes Treatment Product Offered
11.9.3 Adocia Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Adocia Main Business Overview
11.9.5 Adocia Latest Developments
11.10 Peptron
11.10.1 Peptron Company Information
11.10.2 Peptron Gestational Diabetes Treatment Product Offered
11.10.3 Peptron Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Peptron Main Business Overview
11.10.5 Peptron Latest Developments
11.11 AstraZeneca plc
11.11.1 AstraZeneca plc Company Information
11.11.2 AstraZeneca plc Gestational Diabetes Treatment Product Offered
11.11.3 AstraZeneca plc Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 AstraZeneca plc Main Business Overview
11.11.5 AstraZeneca plc Latest Developments
11.12 Pfizer, Inc
11.12.1 Pfizer, Inc Company Information
11.12.2 Pfizer, Inc Gestational Diabetes Treatment Product Offered
11.12.3 Pfizer, Inc Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Pfizer, Inc Main Business Overview
11.12.5 Pfizer, Inc Latest Developments
11.13 Takeda Pharmaceutical Company Ltd
11.13.1 Takeda Pharmaceutical Company Ltd Company Information
11.13.2 Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Product Offered
11.13.3 Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Takeda Pharmaceutical Company Ltd Main Business Overview
11.13.5 Takeda Pharmaceutical Company Ltd Latest Developments
11.14 Abbott
11.14.1 Abbott Company Information
11.14.2 Abbott Gestational Diabetes Treatment Product Offered
11.14.3 Abbott Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Abbott Main Business Overview
11.14.5 Abbott Latest Developments
11.15 Antares Pharma
11.15.1 Antares Pharma Company Information
11.15.2 Antares Pharma Gestational Diabetes Treatment Product Offered
11.15.3 Antares Pharma Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Antares Pharma Main Business Overview
11.15.5 Antares Pharma Latest Developments
11.16 INJEX Pharma AG
11.16.1 INJEX Pharma AG Company Information
11.16.2 INJEX Pharma AG Gestational Diabetes Treatment Product Offered
11.16.3 INJEX Pharma AG Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 INJEX Pharma AG Main Business Overview
11.16.5 INJEX Pharma AG Latest Developments
11.17 Daiichi Sankyo
11.17.1 Daiichi Sankyo Company Information
11.17.2 Daiichi Sankyo Gestational Diabetes Treatment Product Offered
11.17.3 Daiichi Sankyo Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Daiichi Sankyo Main Business Overview
11.17.5 Daiichi Sankyo Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gestational Diabetes Treatment Market Size 2018-2029
2.1.2 Gestational Diabetes Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gestational Diabetes Treatment Segment by Type
2.2.1 Insulin
2.2.2 SGLT-2 Inhibitors
2.2.3 Alpha-glucosidase Inhibitors
2.2.4 Others
2.3 Gestational Diabetes Treatment Market Size by Type
2.3.1 Gestational Diabetes Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gestational Diabetes Treatment Market Size Market Share by Type (2018-2023)
2.4 Gestational Diabetes Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Gestational Diabetes Treatment Market Size by Application
2.5.1 Gestational Diabetes Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gestational Diabetes Treatment Market Size Market Share by Application (2018-2023)
3 GESTATIONAL DIABETES TREATMENT MARKET SIZE BY PLAYER
3.1 Gestational Diabetes Treatment Market Size Market Share by Players
3.1.1 Global Gestational Diabetes Treatment Revenue by Players (2018-2023)
3.1.2 Global Gestational Diabetes Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Gestational Diabetes Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GESTATIONAL DIABETES TREATMENT BY REGIONS
4.1 Gestational Diabetes Treatment Market Size by Regions (2018-2023)
4.2 Americas Gestational Diabetes Treatment Market Size Growth (2018-2023)
4.3 APAC Gestational Diabetes Treatment Market Size Growth (2018-2023)
4.4 Europe Gestational Diabetes Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Gestational Diabetes Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gestational Diabetes Treatment Market Size by Country (2018-2023)
5.2 Americas Gestational Diabetes Treatment Market Size by Type (2018-2023)
5.3 Americas Gestational Diabetes Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gestational Diabetes Treatment Market Size by Region (2018-2023)
6.2 APAC Gestational Diabetes Treatment Market Size by Type (2018-2023)
6.3 APAC Gestational Diabetes Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gestational Diabetes Treatment by Country (2018-2023)
7.2 Europe Gestational Diabetes Treatment Market Size by Type (2018-2023)
7.3 Europe Gestational Diabetes Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gestational Diabetes Treatment by Region (2018-2023)
8.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GESTATIONAL DIABETES TREATMENT MARKET FORECAST
10.1 Global Gestational Diabetes Treatment Forecast by Regions (2024-2029)
10.1.1 Global Gestational Diabetes Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Gestational Diabetes Treatment Forecast
10.1.3 APAC Gestational Diabetes Treatment Forecast
10.1.4 Europe Gestational Diabetes Treatment Forecast
10.1.5 Middle East & Africa Gestational Diabetes Treatment Forecast
10.2 Americas Gestational Diabetes Treatment Forecast by Country (2024-2029)
10.2.1 United States Gestational Diabetes Treatment Market Forecast
10.2.2 Canada Gestational Diabetes Treatment Market Forecast
10.2.3 Mexico Gestational Diabetes Treatment Market Forecast
10.2.4 Brazil Gestational Diabetes Treatment Market Forecast
10.3 APAC Gestational Diabetes Treatment Forecast by Region (2024-2029)
10.3.1 China Gestational Diabetes Treatment Market Forecast
10.3.2 Japan Gestational Diabetes Treatment Market Forecast
10.3.3 Korea Gestational Diabetes Treatment Market Forecast
10.3.4 Southeast Asia Gestational Diabetes Treatment Market Forecast
10.3.5 India Gestational Diabetes Treatment Market Forecast
10.3.6 Australia Gestational Diabetes Treatment Market Forecast
10.4 Europe Gestational Diabetes Treatment Forecast by Country (2024-2029)
10.4.1 Germany Gestational Diabetes Treatment Market Forecast
10.4.2 France Gestational Diabetes Treatment Market Forecast
10.4.3 UK Gestational Diabetes Treatment Market Forecast
10.4.4 Italy Gestational Diabetes Treatment Market Forecast
10.4.5 Russia Gestational Diabetes Treatment Market Forecast
10.5 Middle East & Africa Gestational Diabetes Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Gestational Diabetes Treatment Market Forecast
10.5.2 South Africa Gestational Diabetes Treatment Market Forecast
10.5.3 Israel Gestational Diabetes Treatment Market Forecast
10.5.4 Turkey Gestational Diabetes Treatment Market Forecast
10.5.5 GCC Countries Gestational Diabetes Treatment Market Forecast
10.6 Global Gestational Diabetes Treatment Forecast by Type (2024-2029)
10.7 Global Gestational Diabetes Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biocon Limited
11.1.1 Biocon Limited Company Information
11.1.2 Biocon Limited Gestational Diabetes Treatment Product Offered
11.1.3 Biocon Limited Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biocon Limited Main Business Overview
11.1.5 Biocon Limited Latest Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Information
11.2.2 Eli Lilly Gestational Diabetes Treatment Product Offered
11.2.3 Eli Lilly Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Eli Lilly Main Business Overview
11.2.5 Eli Lilly Latest Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Information
11.3.2 Novo Nordisk Gestational Diabetes Treatment Product Offered
11.3.3 Novo Nordisk Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Novo Nordisk Main Business Overview
11.3.5 Novo Nordisk Latest Developments
11.4 Boehringer Ingelheim GmbH
11.4.1 Boehringer Ingelheim GmbH Company Information
11.4.2 Boehringer Ingelheim GmbH Gestational Diabetes Treatment Product Offered
11.4.3 Boehringer Ingelheim GmbH Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Boehringer Ingelheim GmbH Main Business Overview
11.4.5 Boehringer Ingelheim GmbH Latest Developments
11.5 Sanofi S.A.
11.5.1 Sanofi S.A. Company Information
11.5.2 Sanofi S.A. Gestational Diabetes Treatment Product Offered
11.5.3 Sanofi S.A. Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Sanofi S.A. Main Business Overview
11.5.5 Sanofi S.A. Latest Developments
11.6 Sun Pharmaceutical Industries Limited
11.6.1 Sun Pharmaceutical Industries Limited Company Information
11.6.2 Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Product Offered
11.6.3 Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Sun Pharmaceutical Industries Limited Main Business Overview
11.6.5 Sun Pharmaceutical Industries Limited Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Gestational Diabetes Treatment Product Offered
11.7.3 Merck Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Gestational Diabetes Treatment Product Offered
11.8.3 Novartis Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Novartis Main Business Overview
11.8.5 Novartis Latest Developments
11.9 Adocia
11.9.1 Adocia Company Information
11.9.2 Adocia Gestational Diabetes Treatment Product Offered
11.9.3 Adocia Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Adocia Main Business Overview
11.9.5 Adocia Latest Developments
11.10 Peptron
11.10.1 Peptron Company Information
11.10.2 Peptron Gestational Diabetes Treatment Product Offered
11.10.3 Peptron Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Peptron Main Business Overview
11.10.5 Peptron Latest Developments
11.11 AstraZeneca plc
11.11.1 AstraZeneca plc Company Information
11.11.2 AstraZeneca plc Gestational Diabetes Treatment Product Offered
11.11.3 AstraZeneca plc Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 AstraZeneca plc Main Business Overview
11.11.5 AstraZeneca plc Latest Developments
11.12 Pfizer, Inc
11.12.1 Pfizer, Inc Company Information
11.12.2 Pfizer, Inc Gestational Diabetes Treatment Product Offered
11.12.3 Pfizer, Inc Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Pfizer, Inc Main Business Overview
11.12.5 Pfizer, Inc Latest Developments
11.13 Takeda Pharmaceutical Company Ltd
11.13.1 Takeda Pharmaceutical Company Ltd Company Information
11.13.2 Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Product Offered
11.13.3 Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Takeda Pharmaceutical Company Ltd Main Business Overview
11.13.5 Takeda Pharmaceutical Company Ltd Latest Developments
11.14 Abbott
11.14.1 Abbott Company Information
11.14.2 Abbott Gestational Diabetes Treatment Product Offered
11.14.3 Abbott Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Abbott Main Business Overview
11.14.5 Abbott Latest Developments
11.15 Antares Pharma
11.15.1 Antares Pharma Company Information
11.15.2 Antares Pharma Gestational Diabetes Treatment Product Offered
11.15.3 Antares Pharma Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Antares Pharma Main Business Overview
11.15.5 Antares Pharma Latest Developments
11.16 INJEX Pharma AG
11.16.1 INJEX Pharma AG Company Information
11.16.2 INJEX Pharma AG Gestational Diabetes Treatment Product Offered
11.16.3 INJEX Pharma AG Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 INJEX Pharma AG Main Business Overview
11.16.5 INJEX Pharma AG Latest Developments
11.17 Daiichi Sankyo
11.17.1 Daiichi Sankyo Company Information
11.17.2 Daiichi Sankyo Gestational Diabetes Treatment Product Offered
11.17.3 Daiichi Sankyo Gestational Diabetes Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Daiichi Sankyo Main Business Overview
11.17.5 Daiichi Sankyo Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gestational Diabetes Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Insulin
Table 3. Major Players of SGLT-2 Inhibitors
Table 4. Major Players of Alpha-glucosidase Inhibitors
Table 5. Major Players of Others
Table 6. Gestational Diabetes Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Gestational Diabetes Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Gestational Diabetes Treatment Market Size Market Share by Type (2018-2023)
Table 9. Gestational Diabetes Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Gestational Diabetes Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Gestational Diabetes Treatment Market Size Market Share by Application (2018-2023)
Table 12. Global Gestational Diabetes Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Gestational Diabetes Treatment Revenue Market Share by Player (2018-2023)
Table 14. Gestational Diabetes Treatment Key Players Head office and Products Offered
Table 15. Gestational Diabetes Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Gestational Diabetes Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Gestational Diabetes Treatment Market Size Market Share by Regions (2018-2023)
Table 20. Global Gestational Diabetes Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Gestational Diabetes Treatment Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Gestational Diabetes Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Gestational Diabetes Treatment Market Size Market Share by Country (2018-2023)
Table 24. Americas Gestational Diabetes Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Gestational Diabetes Treatment Market Size Market Share by Type (2018-2023)
Table 26. Americas Gestational Diabetes Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Gestational Diabetes Treatment Market Size Market Share by Application (2018-2023)
Table 28. APAC Gestational Diabetes Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Gestational Diabetes Treatment Market Size Market Share by Region (2018-2023)
Table 30. APAC Gestational Diabetes Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Gestational Diabetes Treatment Market Size Market Share by Type (2018-2023)
Table 32. APAC Gestational Diabetes Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Gestational Diabetes Treatment Market Size Market Share by Application (2018-2023)
Table 34. Europe Gestational Diabetes Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Gestational Diabetes Treatment Market Size Market Share by Country (2018-2023)
Table 36. Europe Gestational Diabetes Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Gestational Diabetes Treatment Market Size Market Share by Type (2018-2023)
Table 38. Europe Gestational Diabetes Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Gestational Diabetes Treatment Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Gestational Diabetes Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gestational Diabetes Treatment Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gestational Diabetes Treatment Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Gestational Diabetes Treatment Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Gestational Diabetes Treatment
Table 47. Key Market Challenges & Risks of Gestational Diabetes Treatment
Table 48. Key Industry Trends of Gestational Diabetes Treatment
Table 49. Global Gestational Diabetes Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Gestational Diabetes Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Gestational Diabetes Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Gestational Diabetes Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Biocon Limited Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 54. Biocon Limited Gestational Diabetes Treatment Product Offered
Table 55. Biocon Limited Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Biocon Limited Main Business
Table 57. Biocon Limited Latest Developments
Table 58. Eli Lilly Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 59. Eli Lilly Gestational Diabetes Treatment Product Offered
Table 60. Eli Lilly Main Business
Table 61. Eli Lilly Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Eli Lilly Latest Developments
Table 63. Novo Nordisk Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 64. Novo Nordisk Gestational Diabetes Treatment Product Offered
Table 65. Novo Nordisk Main Business
Table 66. Novo Nordisk Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Novo Nordisk Latest Developments
Table 68. Boehringer Ingelheim GmbH Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 69. Boehringer Ingelheim GmbH Gestational Diabetes Treatment Product Offered
Table 70. Boehringer Ingelheim GmbH Main Business
Table 71. Boehringer Ingelheim GmbH Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Boehringer Ingelheim GmbH Latest Developments
Table 73. Sanofi S.A. Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 74. Sanofi S.A. Gestational Diabetes Treatment Product Offered
Table 75. Sanofi S.A. Main Business
Table 76. Sanofi S.A. Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Sanofi S.A. Latest Developments
Table 78. Sun Pharmaceutical Industries Limited Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 79. Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Product Offered
Table 80. Sun Pharmaceutical Industries Limited Main Business
Table 81. Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Sun Pharmaceutical Industries Limited Latest Developments
Table 83. Merck Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 84. Merck Gestational Diabetes Treatment Product Offered
Table 85. Merck Main Business
Table 86. Merck Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Merck Latest Developments
Table 88. Novartis Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 89. Novartis Gestational Diabetes Treatment Product Offered
Table 90. Novartis Main Business
Table 91. Novartis Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Novartis Latest Developments
Table 93. Adocia Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 94. Adocia Gestational Diabetes Treatment Product Offered
Table 95. Adocia Main Business
Table 96. Adocia Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Adocia Latest Developments
Table 98. Peptron Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 99. Peptron Gestational Diabetes Treatment Product Offered
Table 100. Peptron Main Business
Table 101. Peptron Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Peptron Latest Developments
Table 103. AstraZeneca plc Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 104. AstraZeneca plc Gestational Diabetes Treatment Product Offered
Table 105. AstraZeneca plc Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. AstraZeneca plc Main Business
Table 107. AstraZeneca plc Latest Developments
Table 108. Pfizer, Inc Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 109. Pfizer, Inc Gestational Diabetes Treatment Product Offered
Table 110. Pfizer, Inc Main Business
Table 111. Pfizer, Inc Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Pfizer, Inc Latest Developments
Table 113. Takeda Pharmaceutical Company Ltd Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 114. Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Product Offered
Table 115. Takeda Pharmaceutical Company Ltd Main Business
Table 116. Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Takeda Pharmaceutical Company Ltd Latest Developments
Table 118. Abbott Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 119. Abbott Gestational Diabetes Treatment Product Offered
Table 120. Abbott Main Business
Table 121. Abbott Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Abbott Latest Developments
Table 123. Antares Pharma Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 124. Antares Pharma Gestational Diabetes Treatment Product Offered
Table 125. Antares Pharma Main Business
Table 126. Antares Pharma Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Antares Pharma Latest Developments
Table 128. INJEX Pharma AG Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 129. INJEX Pharma AG Gestational Diabetes Treatment Product Offered
Table 130. INJEX Pharma AG Main Business
Table 131. INJEX Pharma AG Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. INJEX Pharma AG Latest Developments
Table 133. Daiichi Sankyo Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 134. Daiichi Sankyo Gestational Diabetes Treatment Product Offered
Table 135. Daiichi Sankyo Main Business
Table 136. Daiichi Sankyo Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. Daiichi Sankyo Latest Developments
Table 1. Gestational Diabetes Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Insulin
Table 3. Major Players of SGLT-2 Inhibitors
Table 4. Major Players of Alpha-glucosidase Inhibitors
Table 5. Major Players of Others
Table 6. Gestational Diabetes Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Gestational Diabetes Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Gestational Diabetes Treatment Market Size Market Share by Type (2018-2023)
Table 9. Gestational Diabetes Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Gestational Diabetes Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Gestational Diabetes Treatment Market Size Market Share by Application (2018-2023)
Table 12. Global Gestational Diabetes Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Gestational Diabetes Treatment Revenue Market Share by Player (2018-2023)
Table 14. Gestational Diabetes Treatment Key Players Head office and Products Offered
Table 15. Gestational Diabetes Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Gestational Diabetes Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Gestational Diabetes Treatment Market Size Market Share by Regions (2018-2023)
Table 20. Global Gestational Diabetes Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Gestational Diabetes Treatment Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Gestational Diabetes Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Gestational Diabetes Treatment Market Size Market Share by Country (2018-2023)
Table 24. Americas Gestational Diabetes Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Gestational Diabetes Treatment Market Size Market Share by Type (2018-2023)
Table 26. Americas Gestational Diabetes Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Gestational Diabetes Treatment Market Size Market Share by Application (2018-2023)
Table 28. APAC Gestational Diabetes Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Gestational Diabetes Treatment Market Size Market Share by Region (2018-2023)
Table 30. APAC Gestational Diabetes Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Gestational Diabetes Treatment Market Size Market Share by Type (2018-2023)
Table 32. APAC Gestational Diabetes Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Gestational Diabetes Treatment Market Size Market Share by Application (2018-2023)
Table 34. Europe Gestational Diabetes Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Gestational Diabetes Treatment Market Size Market Share by Country (2018-2023)
Table 36. Europe Gestational Diabetes Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Gestational Diabetes Treatment Market Size Market Share by Type (2018-2023)
Table 38. Europe Gestational Diabetes Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Gestational Diabetes Treatment Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Gestational Diabetes Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gestational Diabetes Treatment Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gestational Diabetes Treatment Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Gestational Diabetes Treatment Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Gestational Diabetes Treatment
Table 47. Key Market Challenges & Risks of Gestational Diabetes Treatment
Table 48. Key Industry Trends of Gestational Diabetes Treatment
Table 49. Global Gestational Diabetes Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Gestational Diabetes Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Gestational Diabetes Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Gestational Diabetes Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Biocon Limited Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 54. Biocon Limited Gestational Diabetes Treatment Product Offered
Table 55. Biocon Limited Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Biocon Limited Main Business
Table 57. Biocon Limited Latest Developments
Table 58. Eli Lilly Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 59. Eli Lilly Gestational Diabetes Treatment Product Offered
Table 60. Eli Lilly Main Business
Table 61. Eli Lilly Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Eli Lilly Latest Developments
Table 63. Novo Nordisk Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 64. Novo Nordisk Gestational Diabetes Treatment Product Offered
Table 65. Novo Nordisk Main Business
Table 66. Novo Nordisk Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Novo Nordisk Latest Developments
Table 68. Boehringer Ingelheim GmbH Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 69. Boehringer Ingelheim GmbH Gestational Diabetes Treatment Product Offered
Table 70. Boehringer Ingelheim GmbH Main Business
Table 71. Boehringer Ingelheim GmbH Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Boehringer Ingelheim GmbH Latest Developments
Table 73. Sanofi S.A. Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 74. Sanofi S.A. Gestational Diabetes Treatment Product Offered
Table 75. Sanofi S.A. Main Business
Table 76. Sanofi S.A. Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Sanofi S.A. Latest Developments
Table 78. Sun Pharmaceutical Industries Limited Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 79. Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Product Offered
Table 80. Sun Pharmaceutical Industries Limited Main Business
Table 81. Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Sun Pharmaceutical Industries Limited Latest Developments
Table 83. Merck Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 84. Merck Gestational Diabetes Treatment Product Offered
Table 85. Merck Main Business
Table 86. Merck Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Merck Latest Developments
Table 88. Novartis Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 89. Novartis Gestational Diabetes Treatment Product Offered
Table 90. Novartis Main Business
Table 91. Novartis Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Novartis Latest Developments
Table 93. Adocia Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 94. Adocia Gestational Diabetes Treatment Product Offered
Table 95. Adocia Main Business
Table 96. Adocia Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Adocia Latest Developments
Table 98. Peptron Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 99. Peptron Gestational Diabetes Treatment Product Offered
Table 100. Peptron Main Business
Table 101. Peptron Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Peptron Latest Developments
Table 103. AstraZeneca plc Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 104. AstraZeneca plc Gestational Diabetes Treatment Product Offered
Table 105. AstraZeneca plc Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. AstraZeneca plc Main Business
Table 107. AstraZeneca plc Latest Developments
Table 108. Pfizer, Inc Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 109. Pfizer, Inc Gestational Diabetes Treatment Product Offered
Table 110. Pfizer, Inc Main Business
Table 111. Pfizer, Inc Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Pfizer, Inc Latest Developments
Table 113. Takeda Pharmaceutical Company Ltd Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 114. Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Product Offered
Table 115. Takeda Pharmaceutical Company Ltd Main Business
Table 116. Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Takeda Pharmaceutical Company Ltd Latest Developments
Table 118. Abbott Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 119. Abbott Gestational Diabetes Treatment Product Offered
Table 120. Abbott Main Business
Table 121. Abbott Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Abbott Latest Developments
Table 123. Antares Pharma Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 124. Antares Pharma Gestational Diabetes Treatment Product Offered
Table 125. Antares Pharma Main Business
Table 126. Antares Pharma Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Antares Pharma Latest Developments
Table 128. INJEX Pharma AG Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 129. INJEX Pharma AG Gestational Diabetes Treatment Product Offered
Table 130. INJEX Pharma AG Main Business
Table 131. INJEX Pharma AG Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. INJEX Pharma AG Latest Developments
Table 133. Daiichi Sankyo Details, Company Type, Gestational Diabetes Treatment Area Served and Its Competitors
Table 134. Daiichi Sankyo Gestational Diabetes Treatment Product Offered
Table 135. Daiichi Sankyo Main Business
Table 136. Daiichi Sankyo Gestational Diabetes Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. Daiichi Sankyo Latest Developments
LIST OF FIGURES
Figure 1. Gestational Diabetes Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gestational Diabetes Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gestational Diabetes Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gestational Diabetes Treatment Sales Market Share by Country/Region (2022)
Figure 8. Gestational Diabetes Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gestational Diabetes Treatment Market Size Market Share by Type in 2022
Figure 10. Gestational Diabetes Treatment in Hospital Pharmacies
Figure 11. Global Gestational Diabetes Treatment Market: Hospital Pharmacies (2018-2023) & ($ Millions)
Figure 12. Gestational Diabetes Treatment in Retail Pharmacies
Figure 13. Global Gestational Diabetes Treatment Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 14. Gestational Diabetes Treatment in Online Pharmacies
Figure 15. Global Gestational Diabetes Treatment Market: Online Pharmacies (2018-2023) & ($ Millions)
Figure 16. Global Gestational Diabetes Treatment Market Size Market Share by Application in 2022
Figure 17. Global Gestational Diabetes Treatment Revenue Market Share by Player in 2022
Figure 18. Global Gestational Diabetes Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Gestational Diabetes Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Gestational Diabetes Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Gestational Diabetes Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Gestational Diabetes Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Gestational Diabetes Treatment Value Market Share by Country in 2022
Figure 24. United States Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Gestational Diabetes Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Gestational Diabetes Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Gestational Diabetes Treatment Market Size Market Share by Application in 2022
Figure 31. China Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Gestational Diabetes Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Gestational Diabetes Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Gestational Diabetes Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Gestational Diabetes Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Gestational Diabetes Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Gestational Diabetes Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Gestational Diabetes Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Gestational Diabetes Treatment Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Gestational Diabetes Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gestational Diabetes Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gestational Diabetes Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gestational Diabetes Treatment Sales Market Share by Country/Region (2022)
Figure 8. Gestational Diabetes Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gestational Diabetes Treatment Market Size Market Share by Type in 2022
Figure 10. Gestational Diabetes Treatment in Hospital Pharmacies
Figure 11. Global Gestational Diabetes Treatment Market: Hospital Pharmacies (2018-2023) & ($ Millions)
Figure 12. Gestational Diabetes Treatment in Retail Pharmacies
Figure 13. Global Gestational Diabetes Treatment Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 14. Gestational Diabetes Treatment in Online Pharmacies
Figure 15. Global Gestational Diabetes Treatment Market: Online Pharmacies (2018-2023) & ($ Millions)
Figure 16. Global Gestational Diabetes Treatment Market Size Market Share by Application in 2022
Figure 17. Global Gestational Diabetes Treatment Revenue Market Share by Player in 2022
Figure 18. Global Gestational Diabetes Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Gestational Diabetes Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Gestational Diabetes Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Gestational Diabetes Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Gestational Diabetes Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Gestational Diabetes Treatment Value Market Share by Country in 2022
Figure 24. United States Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Gestational Diabetes Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Gestational Diabetes Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Gestational Diabetes Treatment Market Size Market Share by Application in 2022
Figure 31. China Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Gestational Diabetes Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Gestational Diabetes Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Gestational Diabetes Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Gestational Diabetes Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Gestational Diabetes Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Gestational Diabetes Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Gestational Diabetes Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Gestational Diabetes Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Gestational Diabetes Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Gestational Diabetes Treatment Market Size Market Share Forecast by Application (2024-2029)
